Physician
Delta Clinics, PLC
Delta Clinics, PLC was paid $2.60M by Medicaid between Jan 2018 and Dec 2024, across 78 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoDELTA CLINICS, PLC
LEXINGTON, TN 38351
LEXINGTON, TN 38351
33aNPI1396033379assigned 07/12/2011
33bProvider typeCardiovascular Disease Physician
28Total paid$2.60M
24GClaims138,055
24DCodes billed78
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in Tennessee
Rank by total paid#3 of 136
Median peer was paid$21K
This provider vs. median123×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,374 | $380K | |
| 2019 | 22,417 | $423K | |
| 2020 | 18,649 | $336K | |
| 2021 | 22,655 | $391K | |
| 2022 | 19,001 | $348K | |
| 2023 | 20,134 | $365K | |
| 2024incomplete | 16,825 | $361K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 36,337 | 28,877 | $733K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 20% | 13,992 | 11,419 | $524K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 10% | 3,642 | 2,674 | $263K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.7% | 15,407 | 12,390 | $228K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 6.5% | 14,594 | 6,609 | $170K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 4.5% | 2,453 | 1,762 | $117K |
| 93458 | 2.5% | 897 | 722 | $64K | |
| 99223 | Prolong inpt eval add15 m | 2.3% | 1,726 | 1,410 | $61K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.5% | 2,318 | 1,106 | $39K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 12,032 | 9,809 | $37K |
| 93298 | 1.3% | 3,335 | 2,903 | $34K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 1.2% | 2,489 | 2,064 | $31K |
66 more codes
| 93015 | 1.2% | 1,504 | $30K | |
| 93925 | 1.1% | 701 | $29K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 582 | $27K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 573 | $21K |
| 78431 | <1% | 96 | $19K | |
| 75574 | <1% | 119 | $13K | |
| 93308 | <1% | 510 | $12K | |
| 93296 | <1% | 2,508 | $11K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 268 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,667 | $9K |
| 93294 | <1% | 1,917 | $9K | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | <1% | 131 | $8K |
| 93018 | <1% | 1,426 | $8K | |
| 93970 | <1% | 151 | $8K | |
| 93325 | <1% | 488 | $7K | |
| 99220 | <1% | 164 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 559 | $6K |
| 93299 | <1% | 572 | $6K | |
| J1245 | Injection, dipyridamole, per 10 mg | <1% | 1,339 | $5K |
| 93295 | <1% | 402 | $5K | |
| 93244 | <1% | 584 | $5K | |
| 93280 | <1% | 825 | $4K | |
| 93321 | <1% | 464 | $4K | |
| 93017 | <1% | 356 | $3K | |
| 93228 | <1% | 383 | $3K | |
| 93242 | <1% | 583 | $3K | |
| 93016 | <1% | 499 | $3K | |
| 93248 | <1% | 293 | $3K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 93 | $2K |
| 93297 | <1% | 484 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 951 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,612 | $2K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 280 | $2K |
| 93880 | <1% | 90 | $1K | |
| 93246 | <1% | 293 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 65 | $1K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 434 | $1K |
| 95251 | <1% | 105 | $1K | |
| 93288 | <1% | 250 | $1K | |
| 93971 | <1% | 36 | $1K | |
| 99217 | <1% | 64 | $991.51 | |
| 93000 | <1% | 144 | $865.38 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 104 | $855.51 |
| 93291 | <1% | 57 | $638.70 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 31 | $607.40 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 44 | $590.11 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 86 | $571.67 |
| 93923 | <1% | 42 | $567.65 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 800 | $547.92 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 101 | $488.57 |
| 93289 | <1% | 48 | $452.61 | |
| 78434 | <1% | 25 | $387.09 | |
| 90674 | <1% | 53 | $264.00 | |
| 93356 | <1% | 20 | $107.46 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 488 | $93.16 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $81.57 |
| G0008 | Administration of influenza virus vaccine | <1% | 14 | $20.98 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 16 | $12.37 |
| 3078F | <1% | 493 | $10.00 | |
| 0296T | <1% | 13 | $6.54 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 19 | $0.35 |
| 3079F | 0% | 383 | $0.00 | |
| 3075F | 0% | 77 | $0.00 | |
| 3074F | 0% | 247 | $0.00 | |
| 3080F | 0% | 52 | $0.00 | |
| 3077F | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOKEWOLE, SIMON (CEO)